Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

" SAVE Study (Switch AdVagraf® to Envarsus®) for Fast Metabolizers Kidney Transplant Recipients"

NCT04945785 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT04945785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04945785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
" SAVE Study (Switch AdVagraf® to Envarsus®) for Fast Metabolizers Kidney Transplant Recipients"
Lead sponsor
Nantes University Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
July 28, 2021
Completion date
May 28, 2026
Enrollment
226 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal transplant failure